ALVO Stock Analysis: Buy, Sell, or Hold?
ALVO - Alvotech Ordinary Shares
$4.43
0.16 (3.75%)
▲
5d:
+9.25%
30d:
+39.31%
90d:
+31.07%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 12, 2026
0d
Get Alerted When ALVO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: ALVO shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: ALVO shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$7.60
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$4.72
6.1% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 15.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ALVO is currently trading at $4.43, which is considered extended relative to its 30-day fair value range of $3.30 to $4.03. From a valuation perspective, the stock is trading at a premium (Forward PE: 17.8) compared to its historical average (15.7). At these levels, the market is pricing in 4.4% annual earnings growth.
Technical Outlook: Technically, ALVO is in a uptrend. Immediate support is located at $3.69, while resistance sits at $4.59. The stock is showing strong short-term momentum, up 3.7% recently.
Market Sentiment: ALVO scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $5.75 (+29.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ALVO is in a uptrend. Immediate support is located at $3.69, while resistance sits at $4.59. The stock is showing strong short-term momentum, up 3.7% recently.
Market Sentiment: ALVO scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $5.75 (+29.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.30 -
$4.03
Company Quality Score
38/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
31.9%
All Signals
- BEARISH: Price extended above range (+9.9% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.7%)
- BULLISH: Trading 29.8% below Wall St target ($5.75)
- BULLISH: Expecting earnings turnaround to 4.4% growth with -20.2% revenue growth
- WARNING: Composite score 38/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.30 -
$4.03
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$3.69
Resistance Level
$4.60
Current Trend
Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
17.82
Wall Street Target
$5.75
(+29.8%)
Revenue Growth (YoY)
-20.2%
Earnings Growth (YoY)
-99.0%
Profit Margin
-14.4%
Valuation Premium vs History
+4.4% premium
PE vs Historical
17.8 vs 15.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.4%
(market-implied from PE analysis)
1-Year Target
$4.62
(+4%)
2-Year Target
$4.83
(+9%)
3-Year Target
$5.04
(+14%)
3-Yr Target (if PE normalizes)
(PE: 18→16)
PE COMPRESSION
$4.44
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: 1755.2%)
$16.84
(+280%)
Base:
(SPY PE: 17.8, Growth: 1755.2%)
$14.95
(+238%)
Bear:
(PE: 15.1, Growth: 1755.2%)
$12.71
(+187%)
Share & Embed Analysis
Last updated: August 23, 2026 7:29 PM ET
Data refreshes hourly during market hours. Next update: 8:29 PM
Data refreshes hourly during market hours. Next update: 8:29 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ALVO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$212 | 67 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$107 | 56 HOLD |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$101 | 43 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$664 | 48 HOLD |
|
LQDA
Liquidia Technologies Inc |
STRONG BUY
10 analysts |
$108 | 55 HOLD |
